VEGFA and neoplasm: Targeting RT to tumor-associated endothelial cells with GNPs can break this tumor-protective cycle–damaged endothelial cells and vasculature will fail to deliver nutrients to tumor tissue, leading to ischemic necrosis and reduced VEGF production.